Important: Stay covered! Are you enrolled in Apple Health (Medicaid) coverage? Make sure your address and phone number are up to date so you can stay enrolled. Report a change.

HCA’s lobby is temporarily closed for walk-in customer service. Learn about customer service options.

Medications for opioid use disorder (MOUD)

Medications for opioid use disorder (MOUD) is an approach to opioid use treatment that combines the use of FDA-approved drugs with counseling and behavioral therapies for people diagnosed with opioid use disorder (OUD).

COVID-19 and buprenorphine-containing products

Find answers to your questions about buprenorphine-containing products in office-based opioid treatment settings in our COVID-19 and prescribing FAQ.

What do I need to know as a provider?

Medication for Opioid Use Disorder (MOUD) is used at opioid treatment program (OTP) facilities as a method for assisting patients in recovery. If you have a patient in need of these services, refer to our listing of opioid treatment programs (OTP) in Washington State.

In addition, the Washington State Targeted Response (STR): Hub and Spoke Project funds multiple, geographically-based, integrated networks of care — called hub and spoke networks — for OUD treatment.

How do I bill?

Learn how to bill for primary care services in a substance use disorder setting and when offering MOUD services:

What is an Opioid Treatment Network (OTN)?

OTNs are second generation hub and spoke treatment sites that serve individuals with opioid use disorder. OTNs are positioned to provide MOUD in nontraditional treatment settings such as emergency departments, jails, syringe services, homeless shelters, and fire departments. These sites initiate medication treatment and make referrals to community providers for ongoing care.

Where are these networks located?

Current OTNs in Washington are located at:

Contact

Megan Fowler
State Opioid Response (SOR) Treatment Manager

Email: megan.fowler@hca.wa.gov
Phone: 360-725-2019